Cancer cells are resistant to apoptosis or in a nutshell do not know when to die. There has been considerable debate on what triggers the genetic mutation that protects cells from apoptosis. It is believed that genetic abnormalities are usually a result of carcinogens like tobacco smoke, radiation, chemicals and infectious agents (some studies have also linked certain viruses with cancer). Since there are numerous intricate and complex cellular interactions that lead to cancer, the exact mechanism of the development of a cancerous cell is unknown.
Genetic abnormalities usually affect apoptosis by triggering two classes of genes. Oncogenes give cells abnormal properties that impart cells resistance to apoptosis, such cells are hyperactive, and are very aggressive in nature. On the other hand, tumour suppressor genes are often deactivated in cancer cells, and such cells continue to produce defective copies of themselves, and their interaction with protective cells of the immune system is also erratic.
In essence, a cancerous cell is incapable of detecting inherited genetic defects, is resistant to apoptosis, is not destroyed by cells of the immune system and can create copies of itself at an accelerated rate.
Cancers are classified based on the type of tissue they originate from:
Carcinomas are malignant tumours derived from epithelial cells. Breast, prostate, lung and colon cancer are usually carcinomas.
Sarcomas are malignant tumours derived from connective tissue, or mesenchymal cells.
Lymphomas and leukaemia are cancers that are a result of uncontrolled growth of cells that form blood
Germ cell tumours are tumours derived from totipotent cells. Totipotent cells are usually found in the testicle and ovary in adults. In children and babies, such cells are found at the base of the spine and the body midline.
Blastic tumours are formed by cells that resemble embryonic tissue, and blastomas are mostly malignant in nature.
It is important to note that not all tumours are malignant in nature and benign tumours usually stop growing once they reach a certain size and are not always life threatening. Nearly 33% of all cancer cases in men are of prostate cancer, making prostate cancer the leading cancer among men. Breast cancer is the most common cancer in women and 32% of all female cancer patients suffer from breast cancer. Interestingly, lung cancer is the leading cause of cancer related deaths in the world.
Cancer Immunotherapy
Unlike radiation therapy and chemotherapy, immunotherapy is a positive treatment and is designed to strengthen the body instead of destroying tissue and cells. Immunotherapy has very little or no side effects when compared to radiation therapy and chemotherapy. In addition, immunotherapy helps the body tolerate and sustain its fight against cancer. Drugs like Alemtuzumab, Bevacizumab, Cetuximab and Rituximab are now regularly used in treating various types of cancer.
Apart from the drugs mentioned above, there are numerous supplements available that help improve the body’s immune system. Certain group of molecules like cytokines and interleukins-2 also help the body fight cancer and have been used in conjunction with immunotherapy. Today, patients can use topical creams for cancer immunotherapy for skin cancers, the cream is commercially known as imiquimod.
For more information on how immune system boosters help treat cancer visit www.mc-s.com.au
Article Source: http://www.articlesdb.net